Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 54, 2019 - Issue 6
Submit an article Journal homepage
1,756
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Limited relevance and progression of histological alterations in the liver during thioguanine therapy in inflammatory bowel disease patients

Dirk P. van AsseldonkDepartment of Gastroenterology and Hepatology, Noordwest Ziekenhuis groep, Alkmaar, the Netherlands;
,
Melek SimsekDepartment of Gastroenterology and Hepatology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-8827-955X
ORCID Icon,
Nanne K. H. de BoerDepartment of Gastroenterology and Hepatology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands;
,
Bindia JharapMeander Medical Center, Department of Gastroenterology and Hepatology, Amersfoort, the Netherlands;
,
Elisabeth BloemenaDepartment of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands;
,
Gijsbert den HartogDepartment of Gastroenterology and Hepatology, Rijnstate Hospital, Arnhem, the Netherlands;
,
Dik B. WesterveldIsala Clinics, Department of Gastroenterology and Hepatology, Zwolle, the Netherlands;
,
Marco C. BecxDepartment of Gastroenterology and Hepatology, Sint Antonius Hospital, Nieuwegein, the Netherlands;
,
Maurice G. RusselDepartment of Gastroenterology and Hepatology, Medisch Spectrum Twente, Enschede, the Netherlands;
,
Birgit I. Lissenberg-WitteDepartment of Epidemiology and Biostatistics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; ORCID Iconhttp://orcid.org/0000-0001-9448-1826
ORCID Icon,
Carin M. van NieuwkerkDepartment of Gastroenterology and Hepatology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands;
,
Chris J. J. MulderDepartment of Gastroenterology and Hepatology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands;
,
Joanne VerheijDepartment of Pathology, Amsterdam UMC, Academical Medical Center, Amsterdam, the Netherlands;
&
Adriaan A. van BodegravenDepartment of Gastroenterology and Hepatology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; ;Zuyderland Medical Centre, Department of Gastroenterology, Geriatrics, Internal and Intensive Care Medicine (Co-MIK), Sittard-Geleen-Heerlen, the Netherlands
 show all
Pages 753-760 | Received 12 Mar 2019, Accepted 27 May 2019, Published online: 16 Jun 2019

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Debbie S. Deben, Dennis R. Wong & Adriaan A. van Bodegraven. (2021) Current status and future perspectives on the use of therapeutic drug monitoring of thiopurine metabolites in patients with inflammatory bowel disease. Expert Opinion on Drug Metabolism & Toxicology 17:12, pages 1433-1444.
Read now
Ahmed B. Bayoumy, Melek Simsek, Margien L. Seinen, Chris J.J. Mulder, Azhar Ansari, Godefridus J. Peters & Nanne K. De Boer. (2020) The continuous rediscovery and the benefit–risk ratio of thioguanine, a comprehensive review. Expert Opinion on Drug Metabolism & Toxicology 16:2, pages 111-123.
Read now

Articles from other publishers (7)

Nanne K H de Boer, Melek Simsek, Berrie Meijer, Markus F Neurath, Ad van Bodegraven & Chris J J Mulder. (2023) Drug rediscovery in gastroenterology: from off-label to on-label use of thioguanine in inflammatory bowel disease. Gut 72:10, pages 1985-1991.
Crossref
Anuraag Jena, Pardhu B Neelam, Harshavardhan Telaprolu, Uday Kiran Mangipudi, Usha Dutta, Shaji Sebastian & Vishal Sharma. (2023) Effectiveness and safety of thioguanine as a maintenance therapy of inflammatory bowel disease: Systematic review, meta-analysis and meta-regression. Clinics and Research in Hepatology and Gastroenterology 47:7, pages 102155.
Crossref
Melek Simsek, Femke Schepers, Sigal Kaplan, Dirk van Asseldonk, Petra van Boeckel, Paul Boekema, Gerard Dijkstra, Herma Fidder, Ingrid Gisbertz, Frank Hoentjen, Bindia Jharap, Frank Kubben, Marleen de Leest, Maarten Meijssen, Ana Petrak, Else van de Poel, Maurice Russel, Adriaan A van Bodegraven, Chris J J Mulder & Nanne de Boer. (2023) Thioguanine is Effective as Maintenance Therapy for Inflammatory Bowel Disease: A Prospective Multicentre Registry Study. Journal of Crohn's and Colitis 17:6, pages 933-942.
Crossref
Paulina Núñez F, Rodrigo Quera, Constanza Bay, Fabiola Castro & Gabriel Mezzano. (2022) Drug-Induced Liver Injury Used in the Treatment of Inflammatory Bowel Disease. Journal of Crohn's and Colitis 16:7, pages 1168-1176.
Crossref
Ahmed B. Bayoumy, Elsa L. S. A. van Liere, Melek Simsek, Ben Warner, Aathavan Loganayagam, Jeremy D. Sanderson, Simon Anderson, Jonathan Nolan, Nanne K. de Boer, Chris J. J. Mulder & Azhar Ansari. (2020) Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease: a retrospective multi-centre study in the United Kingdom. BMC Gastroenterology 20:1.
Crossref
Vince B. C. Biemans, Edo Savelkoul, Ruben Y. Gabriëls, Melek Simsek, Gerard Dijkstra, Marieke J. Pierik, Rachel L. West, Nanne K.H. de Boer & Frank Hoentjen. (2020) A comparative analysis of tioguanine versus low-dose thiopurines combined with allopurinol in inflammatory bowel disease patients. Alimentary Pharmacology & Therapeutics 51:11, pages 1076-1086.
Crossref
. (2019) Azathioprine/mercaptopurine/tioguanine. Reactions Weekly 1773:1, pages 59-59.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.